Developer docs
API playgroundTry for free, no card

Search company profiles

Equashield

Full company profile

uuid0000ghp

Namestring
Equashield
Legal namestring
EQUASHIELD LLC
Websiteurl
equashield.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

EQUASHIELD is a privately held medical device company that specializes in Closed System Transfer Devices (CSTDs) and adjacent automated compounding technologies for the safe handling of hazardous drugs used in chemotherapy and other sterile clinical settings. Founded in 2004 and headquartered in Port Washington, New York, with manufacturing operations in Israel, the company serves hospital pharmacies, oncology nurses, compounding pharmacists, biopharmaceutical manufacturers, CDMOs, and veterinary professionals across more than 25 countries spanning five continents. EQUASHIELD has been named the most-used CSTD in the United States for nine consecutive years and holds approximately 44% US market share, with a customer base of more than 3,000 hospitals and a customer retention rate above 99%.

The company's core offering is a portfolio of proprietary CSTD components — closed-back syringe units (sizes from 1 mL to 60 mL), vial adaptors, spike adaptors, female connectors, luer lock adaptors, and IV tubing sets — built around an integrated barrier-type pressure equalization system and a leak-preventing dry disconnection mechanism that mechanically prevent vapor escape and microbial ingress. On top of this hardware base, the company has layered an automated compounding platform: Mundus HD for general hazardous drug compounding at up to 37 doses per hour, Mundus Neo for pediatric and neonatal precision dosing, and EQUASHIELD Pro for high-throughput compounding at up to 70 doses per hour. The Mundus systems use embedded cameras and machine vision to verify every dose three times and integrate with electronic medical records (EMR) for digital order-to-administration workflows. The company has also extended its closed-system technology via CellSHIELD into cell and gene therapy manufacturing for biopharma and CDMOs. Four US patents (US 8,196,614; US 10,398,627; US 10,765,601; US 9,610,222) protect the core syringe and adaptor technology, and regulatory clearances include FDA 510(k) under product code ONB (K221513) and CE mark under EU MDR 2017/745.

EQUASHIELD generates revenue primarily through hardware sales of CSTD components and capital equipment, supplemented by clinical training services and a compliance platform partnership with Pharmacy Stars. Distribution follows a hybrid model: a direct enterprise field sales force and clinical account managers in the United States, complemented by every major US wholesaler (ABC, Cardinal Health, McKesson, Morris & Dickson, Oncology Supply, Owens & Minor, Medline, Concordance) and regional distributors internationally; U.S. customers can also order directly through an online portal. Marketing is content-driven, anchored by the EQ Academy educational platform, peer-reviewed clinical studies, and a heavy presence at ASHP and similar industry events. In October 2022, Nordic Capital acquired a major stake with a reported $300 million investment to support expansion of AI-enabled automated compounding and global growth.

Short descriptiontext

EQUASHIELD is a privately held medical device company that develops Closed System Transfer Devices (CSTDs) and AI-powered automated compounding systems for safe handling of hazardous drugs, serving 3,000+ hospitals globally with 44% US CSTD market share.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersPort Washington, United States
HQ citystring
Port Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
closed system transfer devices, hazardous drug handling, automated pharmacy compounding, chemotherapy safety devices, sterile compounding systems
Industry2 codes
PRIMARYHLACAKAM
Compounding Pharmacy & Sterile Prep Workflow Systems
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices — Closed System Transfer Devices (CSTDs) for Hazardous Drug Handling
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1CSTD Products (Syringe Units, Vial Adaptors, Spike Adaptors)
TypeHardware Sales
Description

Sale of closed system transfer device components including syringe units in multiple sizes (1mL to 60mL), vial adaptors (13mm to 32mm), spike adaptors, and accessories. Products sold through distributor network and direct sales.

equashield.com
2Automated Compounding Systems (Mundus HD, Mundus Neo)
TypeHardware Sales
Description

Sale of automated compounding equipment including Mundus HD and Mundus Neo systems with AI-powered image processing capabilities. Includes modular design for pharmacy workflow integration.

equashield.com
3Consumables and Accessories
TypeHardware Sales
Description

Recurring revenue from consumable CSTD components and accessories including tubing sets, luer lock adaptors, female connectors, and protective plugs that require ongoing repurchase.

equashield.com
4Clinical Training and Compliance Services
TypeProfessional Services
Description

Premium clinical and educational support services including on-site training, clinical consulting, quarterly visits, and ongoing support. Partnership with Pharmacy Stars for compliance platform services.

equashield.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Marketing or Sales, Technology or R&D, Supply Chain
Pricing details2 tiers
1Standard CSTD components available through wholesale distribution
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products sold in box and case quantities through distributor network with SKU numbers for major wholesalers (ABC, Cardinal, McKesson, etc.)

equashield.com
2Automated compounding systems with customized purchasing plans
ModelOtherBilling cadenceMulti-year contract
Notes

Mundus HD and Mundus Neo systems offered with customized purchasing plans to meet specific facility needs. Cost-effective modular design emphasizes ROI.

equashield.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1CellSHIELD
Description

IP-protected closed family of devices for cell/gene therapy manufacturing ensuring prevention of microbial contamination

equashield.com
+4 more records
Core offering1 text field

Equashield manufactures and sells the EQUASHIELD Closed System Transfer Device (CSTD) platform — proprietary closed-back syringes, vial adaptors, spike adaptors, female connectors, luer lock adaptors, and IV tubing sets that prevent hazardous drug vapor escape, aerosol leakage, and microbial ingress during chemotherapy compounding and administration. The company complements its manual CSTD system with AI-enabled automated pharmacy compounding equipment (Mundus HD, Mundus Neo, and EQUASHIELD Pro) using machine vision for dose verification, and the CellSHIELD device family for cell/gene therapy sterile manufacturing. Products are sold to hospital pharmacies, oncology clinics, biopharma companies, and CDMOs through direct sales, an online ordering portal, and a network of national and international distributors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 44% of CSTDs in use for hazardous drug preparation in US hospitals
+9 more records
Product overview1 text field

EQUASHIELD is a global compounding technology company offering a unified product ecosystem centered on hazardous drug handling safety. The core portfolio consists of EQUASHIELD CSTD (Closed System Transfer Device) technology including closed-back syringe units, vial adaptors, spike adaptors, female connectors, luer lock adaptors, and IV tubing sets. This manual CSTD system is complemented by automated compounding solutions: Mundus HD for general hazardous drug compounding (up to 37 doses/hour), Mundus Neo for pediatric precision compounding, and EQUASHIELD Pro for high-throughput needs (up to 70 doses/hour). The CellSHIELD product line addresses cell/gene therapy sterile manufacturing. Additional offerings include EQ Academy educational resources and Pharmacy Stars compliance platform integration. All products share the common goal of protecting healthcare workers from hazardous drug exposure through closed-system technology.

Product and service14 records
1EQUASHIELD CSTD (Closed System Transfer Device) System
CategoryClosed System Transfer Device (CSTD)
Description

Industry-leading closed system transfer device platform with closed-back syringe units and adaptors for hazardous drug compounding and administration. Features integrated barrier-type pressure equalization, leak-preventing dry disconnection mechanism, and encapsulated plunger rod to prevent vapor escape and contamination. Sold to hospital pharmacies, oncology clinics, and compounding facilities.

2Mundus HD
CategoryAutomated Pharmacy Compounding System
Description

Automated hazardous drug compounding solution using EQUASHIELD's proven CSTDs with automation, embedded cameras, machine vision, and AI-powered image analysis for dose verification. Delivers up to 37 individual doses per hour with full traceability, complete documentation, and EMR integration for hospital pharmacy customers.

3Mundus Neo
CategoryAutomated Pharmacy Compounding System
Description

Automated pediatric compounding system with precision-guided dosing, validated double-membrane design to prevent microbial contamination, and advanced accuracy for small doses. Designed for neonatal and pediatric hospital pharmacy customers, with complete documentation and traceability.

4EQUASHIELD Pro
CategoryAutomated Pharmacy Compounding System
Description

High-throughput automated compounding robot producing up to 70 doses per hour with the smallest footprint in the industry. Uses CSTD from start to finish for maximum safety, efficiency, and accuracy in hazardous drug compounding for hospital pharmacy customers.

5CellSHIELD
CategoryCell/Gene Therapy Manufacturing Devices
Description

IP-protected closed family of devices for cell/gene therapy sterile manufacturing that prevents microbial contamination throughout cell therapy production processes. Enables biopharma companies and CDMOs to safely scale up manufacturing operations without expensive Grade A biosafety cabinets. Targeted at biopharma manufacturers and CDMOs.

6EQUASHIELD Syringe Units (SU Series)
CategoryCSTD Components (Consumables)
Description

Closed-back syringe units with integrated pressure equalization system that prevent vapor and aerosol escape. Available in sizes from 1mL to 60mL with permanently bonded connectors and shielded needles for needlestick prevention. Consumable component sold to hospital pharmacies for hazardous drug compounding.

7Vial Adaptors (VA Series)
CategoryCSTD Components (Consumables)
Description

Snap-on vial adaptors providing contamination-free vial access with a microbial barrier preventing ingress for up to 10 connections in 7 days. Available in multiple sizes (13mm to 32mm) including concave variants for thick stoppers. Consumable component for hazardous drug handling.

8Spike Adaptors (SA Series)
CategoryCSTD Components (Consumables)
Description

Secure IV bag connection adaptors facilitating safe transfer of hazardous drugs. Includes SA-EZ, SA-EZ/D, SA-180, SA-1J, and SA-EZM variants with internal locking mechanisms preventing accidental disconnection.

9Female Connectors (FC Series)
CategoryCSTD Components (Consumables)
Description

Leak-free female luer lock connectors that convert standard ports into closed system connections. Includes FC-1 standard and FC-1S swivel variants with dual membranes preventing drug residues and enabling dry connections.

10Luer Lock Adaptors (LL Series)
CategoryCSTD Components (Consumables)
Description

Secure connections to patient lines for safe injection and infusion, including LL-2, LL-2S (swivel), LL-2C (catheter), and multipack variants with enclosed lever for safe disengagement.

11IV Tubing Sets
CategoryCSTD Components (Consumables)
Description

Integrated tubing sets combining spike adaptors or luer-lock adaptors with tubing for safe medication transfer to IV bags. Includes SA-EZ/E, SA-EZ/ST, SA-EZ/F (with filter for Paclitaxel), and LL-1Y Y-site tubing variants.

12SA-180 & FC-180 Set
CategoryCSTD Components (Consumables)
Description

Combined spike adaptor and female luer lock connector set for efficient preparation and administration of multiple chemotherapy drugs. Reduces components needed and enables flexible multi-drug treatment workflows.

13EQUASHIELD Safety Platform
CategoryIntegrated Safety Platform
Description

Comprehensive integrated safety platform combining CSTD technology with automated compounding and IV workflow software. Offers automated safety checks and seamless workflow standardization for hospital pharmacy hazardous drug handling.

14Pharmacy Stars Compounding360 Compliance Platform Integration
CategoryPharmacy Compliance Software/Service
Description

Cloud-based pharmacy regulatory compliance platform offered in partnership with Pharmacy Stars. Combines EQUASHIELD CSTD technology with Compounding360 software for USP, NAPRA, TJC, and 340B compliance management, SOPs, and year-round CSTD training across health systems.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership for pharmacy compliance solutions. Combines EQUASHIELD's CSTD technology with Pharmacy Stars' Compounding360 cloud-based compliance platform. Joint offerings include year-round CSTD training, USP 797 compliance support, and exclusive partnership discounts for new and existing customers.

2Local Recycling Organizations
Strategic tierMinorTypeOthers
Description

Partnerships with local recycling organizations to recycle approximately 40 tons of plastic manufacturing residues annually, contributing to circular economy initiatives and sustainable manufacturing practices.

prnewswire.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BD manufactures the BD PhaSeal Closed System Transfer Device, the original CSTD launched in the late 1990s. BD is the most direct competitor to EQUASHIELD in hospital pharmacy hazardous drug handling and operates with significantly broader portfolio and resources.

TypeDirect peer
Description

ICU Medical produces the ChemoClave CSTD system and competes head-to-head with EQUASHIELD in hazardous drug compounding. The company also offers broader IV therapy and critical care products, making it a strong direct competitor with adjacent portfolio leverage.

TypeDirect peer
Description

B. Braun manufactures the OnGuard CSTD system and TPN compounding equipment, directly competing with EQUASHIELD in hazardous drug and sterile compounding safety. B. Braun's large global footprint and broad hospital supplies portfolio make it a meaningful direct peer.

4Terumo Medical
TypeDirect peer
Description

Terumo manufactures closed system drug transfer devices and broader drug delivery / infusion products, including Surplug and related CSTD offerings. Terumo overlaps with EQUASHIELD's CSTD product line and shares exposure to hospital pharmacy compounding workflows.

TypeEmerging player
Description

Yukon Medical is a smaller specialized CSTD competitor offering closed system transfer devices for hazardous drug handling. It is a direct niche competitor to EQUASHIELD with a narrower product portfolio and limited geographic reach.

TypeEmerging player
Description

Corvida Medical has developed the Halo Closed System Transfer Device as a newer entrant in the CSTD category. It competes with EQUASHIELD in hazardous drug safety with technology focused on usability improvements.

TypeBroad incumbent
Description

Baxter offers a broad hospital products portfolio including IV solutions, infusion pumps, and pharmacy compounding technologies. While not a pure-play CSTD competitor, Baxter overlaps with EQUASHIELD's hospital pharmacy and compounding workflow offerings.

8Smiths Medical
TypeBroad incumbent
Description

Smiths Medical manufactures specialty medical devices including infusion systems and related drug delivery products relevant to hazardous drug administration. It is comparable as a broader hospital-focused medical device peer adjacent to EQUASHIELD's compounding focus.

TypeOthers
Description

West Pharmaceutical Services manufactures drug containment and delivery components including stoppers, seals, and syringe components used in injectable drug packaging. It is comparable to EQUASHIELD at the component level for injectable and parenteral drug handling.

TypeBroad incumbent
Description

Cytiva, part of Danaher, provides bioprocessing and cell/gene therapy manufacturing technologies including single-use systems and sterile connectors. It is comparable to EQUASHIELD's CellSHIELD business serving cell/gene therapy manufacturing workflows at CDMOs and biopharma companies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Equashield

Medical Devices — Closed System Transfer Devices (CSTDs) for Hazardous Drug Handlingequashield.com

EQUASHIELD is a privately held medical device company that develops Closed System Transfer Devices (CSTDs) and AI-powered automated compounding systems for safe handling of hazardous drugs, serving 3,000+ hospitals globally with 44% US CSTD market share.

What Equashield does

EQUASHIELD is a privately held medical device company that specializes in Closed System Transfer Devices (CSTDs) and adjacent automated compounding technologies for the safe handling of hazardous drugs used in chemotherapy and other sterile clinical settings. Founded in 2004 and headquartered in Port Washington, New York, with manufacturing operations in Israel, the company serves hospital pharmacies, oncology nurses, compounding pharmacists, biopharmaceutical manufacturers, CDMOs, and veterinary professionals across more than 25 countries spanning five continents. EQUASHIELD has been named the most-used CSTD in the United States for nine consecutive years and holds approximately 44% US market share, with a customer base of more than 3,000 hospitals and a customer retention rate above 99%.

The company's core offering is a portfolio of proprietary CSTD components — closed-back syringe units (sizes from 1 mL to 60 mL), vial adaptors, spike adaptors, female connectors, luer lock adaptors, and IV tubing sets — built around an integrated barrier-type pressure equalization system and a leak-preventing dry disconnection mechanism that mechanically prevent vapor escape and microbial ingress. On top of this hardware base, the company has layered an automated compounding platform: Mundus HD for general hazardous drug compounding at up to 37 doses per hour, Mundus Neo for pediatric and neonatal precision dosing, and EQUASHIELD Pro for high-throughput compounding at up to 70 doses per hour. The Mundus systems use embedded cameras and machine vision to verify every dose three times and integrate with electronic medical records (EMR) for digital order-to-administration workflows. The company has also extended its closed-system technology via CellSHIELD into cell and gene therapy manufacturing for biopharma and CDMOs. Four US patents (US 8,196,614; US 10,398,627; US 10,765,601; US 9,610,222) protect the core syringe and adaptor technology, and regulatory clearances include FDA 510(k) under product code ONB (K221513) and CE mark under EU MDR 2017/745.

EQUASHIELD generates revenue primarily through hardware sales of CSTD components and capital equipment, supplemented by clinical training services and a compliance platform partnership with Pharmacy Stars. Distribution follows a hybrid model: a direct enterprise field sales force and clinical account managers in the United States, complemented by every major US wholesaler (ABC, Cardinal Health, McKesson, Morris & Dickson, Oncology Supply, Owens & Minor, Medline, Concordance) and regional distributors internationally; U.S. customers can also order directly through an online portal. Marketing is content-driven, anchored by the EQ Academy educational platform, peer-reviewed clinical studies, and a heavy presence at ASHP and similar industry events. In October 2022, Nordic Capital acquired a major stake with a reported $300 million investment to support expansion of AI-enabled automated compounding and global growth.

Equashield firmographics

Firmographics
Name
Equashield
Legal name
EQUASHIELD LLC
Website
https://equashield.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
101–250 employees
Short description
EQUASHIELD is a privately held medical device company that develops Closed System Transfer Devices (CSTDs) and AI-powered automated compounding systems for safe handling of hazardous drugs, serving 3,000+ hospitals globally with 44% US CSTD market share.
Ownership category
akta.pro rank

Equashield industry classification

Industry
Product category
Medical Devices — Closed System Transfer Devices (CSTDs) for Hazardous Drug Handling
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACAKAM
Compounding Pharmacy & Sterile Prep Workflow Systems
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Closed system transfer devices
  • Hazardous drug handling
  • Automated pharmacy compounding
  • Chemotherapy safety devices
  • Sterile compounding systems

Where Equashield is headquartered

Location

Headquarters

HQ city
Port Washington
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Equashield business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. CSTD Products (Syringe Units, Vial Adaptors, Spike Adaptors): Sale of closed system transfer device components including syringe units in multiple sizes (1mL to 60mL), vial adaptors (13mm to 32mm), spike adaptors, and accessories. Products sold through distributor network and direct sales.
  2. Automated Compounding Systems (Mundus HD, Mundus Neo): Sale of automated compounding equipment including Mundus HD and Mundus Neo systems with AI-powered image processing capabilities. Includes modular design for pharmacy workflow integration.
  3. Consumables and Accessories: Recurring revenue from consumable CSTD components and accessories including tubing sets, luer lock adaptors, female connectors, and protective plugs that require ongoing repurchase.
  4. Clinical Training and Compliance Services: Premium clinical and educational support services including on-site training, clinical consulting, quarterly visits, and ongoing support. Partnership with Pharmacy Stars for compliance platform services.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard CSTD components available through wholesale distribution
OtherMulti-year contractAutomated compounding systems with customized purchasing plans

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Equashield product offering

Product offering

Core offering

Equashield manufactures and sells the EQUASHIELD Closed System Transfer Device (CSTD) platform — proprietary closed-back syringes, vial adaptors, spike adaptors, female connectors, luer lock adaptors, and IV tubing sets that prevent hazardous drug vapor escape, aerosol leakage, and microbial ingress during chemotherapy compounding and administration. The company complements its manual CSTD system with AI-enabled automated pharmacy compounding equipment (Mundus HD, Mundus Neo, and EQUASHIELD Pro) using machine vision for dose verification, and the CellSHIELD device family for cell/gene therapy sterile manufacturing. Products are sold to hospital pharmacies, oncology clinics, biopharma companies, and CDMOs through direct sales, an online ordering portal, and a network of national and international distributors.

Product overview

EQUASHIELD is a global compounding technology company offering a unified product ecosystem centered on hazardous drug handling safety. The core portfolio consists of EQUASHIELD CSTD (Closed System Transfer Device) technology including closed-back syringe units, vial adaptors, spike adaptors, female connectors, luer lock adaptors, and IV tubing sets. This manual CSTD system is complemented by automated compounding solutions: Mundus HD for general hazardous drug compounding (up to 37 doses/hour), Mundus Neo for pediatric precision compounding, and EQUASHIELD Pro for high-throughput needs (up to 70 doses/hour). The CellSHIELD product line addresses cell/gene therapy sterile manufacturing. Additional offerings include EQ Academy educational resources and Pharmacy Stars compliance platform integration. All products share the common goal of protecting healthcare workers from hazardous drug exposure through closed-system technology.

Differentiator

Problem solved

Functional benefit

Brands

  • CellSHIELD: IP-protected closed family of devices for cell/gene therapy manufacturing ensuring prevention of microbial contamination
  • Mundus HD
  • Mundus Neo
  • EQUASHIELD Pro
  • EQUASHIELD Pro

Products and services

  • EQUASHIELD CSTD (Closed System Transfer Device) System Industry-leading closed system transfer device platform with closed-back syringe units and adaptors for hazardous drug compounding and administration. Features integrated barrier-type pressure equalization, leak-preventing dry disconnection mechanism, and encapsulated plunger rod to prevent vapor escape and contamination. Sold to hospital pharmacies, oncology clinics, and compounding facilities.
  • Mundus HD Automated hazardous drug compounding solution using EQUASHIELD's proven CSTDs with automation, embedded cameras, machine vision, and AI-powered image analysis for dose verification. Delivers up to 37 individual doses per hour with full traceability, complete documentation, and EMR integration for hospital pharmacy customers.
  • Mundus Neo Automated pediatric compounding system with precision-guided dosing, validated double-membrane design to prevent microbial contamination, and advanced accuracy for small doses. Designed for neonatal and pediatric hospital pharmacy customers, with complete documentation and traceability.
  • EQUASHIELD Pro High-throughput automated compounding robot producing up to 70 doses per hour with the smallest footprint in the industry. Uses CSTD from start to finish for maximum safety, efficiency, and accuracy in hazardous drug compounding for hospital pharmacy customers.
  • CellSHIELD IP-protected closed family of devices for cell/gene therapy sterile manufacturing that prevents microbial contamination throughout cell therapy production processes. Enables biopharma companies and CDMOs to safely scale up manufacturing operations without expensive Grade A biosafety cabinets. Targeted at biopharma manufacturers and CDMOs.
  • EQUASHIELD Syringe Units (SU Series) Closed-back syringe units with integrated pressure equalization system that prevent vapor and aerosol escape. Available in sizes from 1mL to 60mL with permanently bonded connectors and shielded needles for needlestick prevention. Consumable component sold to hospital pharmacies for hazardous drug compounding.
  • Vial Adaptors (VA Series) Snap-on vial adaptors providing contamination-free vial access with a microbial barrier preventing ingress for up to 10 connections in 7 days. Available in multiple sizes (13mm to 32mm) including concave variants for thick stoppers. Consumable component for hazardous drug handling.
  • Spike Adaptors (SA Series) Secure IV bag connection adaptors facilitating safe transfer of hazardous drugs. Includes SA-EZ, SA-EZ/D, SA-180, SA-1J, and SA-EZM variants with internal locking mechanisms preventing accidental disconnection.
  • Female Connectors (FC Series) Leak-free female luer lock connectors that convert standard ports into closed system connections. Includes FC-1 standard and FC-1S swivel variants with dual membranes preventing drug residues and enabling dry connections.
  • Luer Lock Adaptors (LL Series) Secure connections to patient lines for safe injection and infusion, including LL-2, LL-2S (swivel), LL-2C (catheter), and multipack variants with enclosed lever for safe disengagement.
  • IV Tubing Sets Integrated tubing sets combining spike adaptors or luer-lock adaptors with tubing for safe medication transfer to IV bags. Includes SA-EZ/E, SA-EZ/ST, SA-EZ/F (with filter for Paclitaxel), and LL-1Y Y-site tubing variants.
  • SA-180 & FC-180 Set Combined spike adaptor and female luer lock connector set for efficient preparation and administration of multiple chemotherapy drugs. Reduces components needed and enables flexible multi-drug treatment workflows.
  • EQUASHIELD Safety Platform Comprehensive integrated safety platform combining CSTD technology with automated compounding and IV workflow software. Offers automated safety checks and seamless workflow standardization for hospital pharmacy hazardous drug handling.
  • Pharmacy Stars Compounding360 Compliance Platform Integration Cloud-based pharmacy regulatory compliance platform offered in partnership with Pharmacy Stars. Combines EQUASHIELD CSTD technology with Compounding360 software for USP, NAPRA, TJC, and 340B compliance management, SOPs, and year-round CSTD training across health systems.

Quantifiable outcome

  • 44% of CSTDs in use for hazardous drug preparation in US hospitals
  • +9 more outcomes

Companies that use Equashield

Customer profile

Named customers2 records

Segments7 records

Ideal customer profiles4 records

Equashield technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability7 records

Feature6 records

Equashield partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Pharmacy StarscoreStrategic or Co-development PartnerStrategic partnership for pharmacy compliance solutions. Combines EQUASHIELD's CSTD technology with Pharmacy Stars' Compounding360 cloud-based compliance platform. Joint offerings include year-round CSTD training, USP 797 compliance support, and exclusive partnership discounts for new and existing customers.
  • Local Recycling OrganizationsminorOthersPartnerships with local recycling organizations to recycle approximately 40 tons of plastic manufacturing residues annually, contributing to circular economy initiatives and sustainable manufacturing practices.

Scale indicators8 records

Recent moves6 records

Expansion highlights7 records

Equashield competitors and assessment

Company assessment

Direct peers

  • Becton Dickinson (BD): BD manufactures the BD PhaSeal Closed System Transfer Device, the original CSTD launched in the late 1990s. BD is the most direct competitor to EQUASHIELD in hospital pharmacy hazardous drug handling and operates with significantly broader portfolio and resources.
  • ICU Medical: ICU Medical produces the ChemoClave CSTD system and competes head-to-head with EQUASHIELD in hazardous drug compounding. The company also offers broader IV therapy and critical care products, making it a strong direct competitor with adjacent portfolio leverage.
  • B. Braun Medical: B. Braun manufactures the OnGuard CSTD system and TPN compounding equipment, directly competing with EQUASHIELD in hazardous drug and sterile compounding safety. B. Braun's large global footprint and broad hospital supplies portfolio make it a meaningful direct peer.
  • Terumo Medical: Terumo manufactures closed system drug transfer devices and broader drug delivery / infusion products, including Surplug and related CSTD offerings. Terumo overlaps with EQUASHIELD's CSTD product line and shares exposure to hospital pharmacy compounding workflows.

Emerging players

  • Yukon Medical: Yukon Medical is a smaller specialized CSTD competitor offering closed system transfer devices for hazardous drug handling. It is a direct niche competitor to EQUASHIELD with a narrower product portfolio and limited geographic reach.
  • Corvida Medical: Corvida Medical has developed the Halo Closed System Transfer Device as a newer entrant in the CSTD category. It competes with EQUASHIELD in hazardous drug safety with technology focused on usability improvements.

Broad incumbents

  • Baxter International: Baxter offers a broad hospital products portfolio including IV solutions, infusion pumps, and pharmacy compounding technologies. While not a pure-play CSTD competitor, Baxter overlaps with EQUASHIELD's hospital pharmacy and compounding workflow offerings.
  • Smiths Medical: Smiths Medical manufactures specialty medical devices including infusion systems and related drug delivery products relevant to hazardous drug administration. It is comparable as a broader hospital-focused medical device peer adjacent to EQUASHIELD's compounding focus.
  • Cytiva (Danaher): Cytiva, part of Danaher, provides bioprocessing and cell/gene therapy manufacturing technologies including single-use systems and sterile connectors. It is comparable to EQUASHIELD's CellSHIELD business serving cell/gene therapy manufacturing workflows at CDMOs and biopharma companies.

Others

  • West Pharmaceutical Services: West Pharmaceutical Services manufactures drug containment and delivery components including stoppers, seals, and syringe components used in injectable drug packaging. It is comparable to EQUASHIELD at the component level for injectable and parenteral drug handling.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Equashield social profiles

Digital presence

Equashield compliance and trust

Trust signal

Compliance2 records

Equashield financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Equashield leadership team

Management profile

Number of profiles

Profiles6 records

Equashield funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Equashield M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Equashield

What does Equashield do?

Equashield manufactures and sells the EQUASHIELD Closed System Transfer Device (CSTD) platform — proprietary closed-back syringes, vial adaptors, spike adaptors, female connectors, luer lock adaptors, and IV tubing sets that prevent hazardous drug vapor escape, aerosol leakage, and microbial ingress during chemotherapy compounding and administration. The company complements its manual CSTD system with AI-enabled automated pharmacy compounding equipment (Mundus HD, Mundus Neo, and EQUASHIELD Pro) using machine vision for dose verification, and the CellSHIELD device family for cell/gene therapy sterile manufacturing. Products are sold to hospital pharmacies, oncology clinics, biopharma companies, and CDMOs through direct sales, an online ordering portal, and a network of national and international distributors.

Is Equashield a public or private company?

Equashield is a private company. It is classified as private equity controlled and is currently operating.

When was Equashield founded?

Equashield was founded in 2012. It employs 101 to 250 people.

Where is Equashield based?

Equashield is headquartered in Port Washington, United States, in the North America region.

How does Equashield make money?

Four revenue lines are on record. CSTD Products (Syringe Units, Vial Adaptors, Spike Adaptors) is the primary driver. The others are automated Compounding Systems (Mundus HD, Mundus Neo), consumables and Accessories and clinical Training and Compliance Services.

Who are Equashield's main competitors?

Direct peers on record are Becton Dickinson (BD), ICU Medical, B. Braun Medical and Terumo Medical. Emerging players are Yukon Medical and Corvida Medical. Broad incumbents are Baxter International, Smiths Medical and Cytiva (Danaher). West Pharmaceutical Services is listed as an others.

Does Equashield have an API?

No public API is recorded for Equashield.

What industry is Equashield in?

Equashield's product category is Medical Devices — Closed System Transfer Devices (CSTDs) for Hazardous Drug Handling. Its primary akta.pro industry code is HLACAKAM, Compounding Pharmacy & Sterile Prep Workflow Systems, with a secondary code of HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageFour Industry Sponsors Commit $100,000 to Launch the Medicinal Hazard Data Standardization ConsortiumPharmacy Stars, BD, EQUASHIELD, and EuroBioConcept have collectively provided $100,000 to launch the Medicinal Hazard Data Standardization Consortium, a nonprofit developing standardized Medicinal Hazard Data Sheets. The funding addresses fragmented hazardous drug classification across NIOSH, USP, ISOPP, and European directives, with outputs made freely available.PR NewswireEQUASHIELD® Named Most-Used CSTD in the U.S. for Eighth Consecutive YearEQUASHIELD® has been named the most-used Closed System Transfer Device (CSTD) for hazardous drug preparation in the United States for the eighth consecutive year, according to the Pharmacy Purchasing & Products State of Pharmacy Compounding Report. The company now accounts for 44 percent of CSTDs in use, with nearly 80 percent of U.S. healthcare facilities preparing hazardous drugs and 93 percent relying on CSTDs. EQUASHIELD® is expanding its safety platform beyond manual compounding with the Mundus HD automated pharmacy compounding system.PR NewswireEQUASHIELD® Marks Earth Day with Transition to eIFU, Advancing Sustainability Across OperationsEQUASHIELD, a global leader in hazardous drug handling, announced on Earth Day 2026 its transition to electronic Instructions for Use (eIFU), eliminating approximately 160,000 pounds of paper waste annually while maintaining regulatory compliance. The company also reported that all its packaging now uses 100% recycled materials and that it recycles 40 tons of plastic manufacturing residues through partnerships with local recycling organizations. The initiative is part of EQUASHIELD's broader Environmental, Social and Governance (ESG) strategy aimed at advancing sustainability in healthcare manufacturing.AsepticenclosuresInnovations in Sterile Compounding Equipment: Enhancing Safety and AccuracyThis article is a promotional/informational piece about sterile compounding equipment and technologies, rather than a news article reporting a specific event. It discusses advances in automation and robotics integrated into sterile compounding equipment, highlighting Automated Compounding Devices like the ExactaMix system by Baxa, robotic systems like RIVA by ARxIUM, environmental monitoring systems including particle counters and viable particle samplers, and Closed System Transfer Devices like Equashield. Aseptic Enclosures promotes its cleanroom solutions and isolators designed to support these technologies.EIN PresswireChartwell Pharmacy Becomes First Facility in US to Showcase EQUASHIELD’s Mundus Compounding SystemChartwell Pharmacy became the first facility in the US to showcase the EQUASHIELD Mundus Compounding System, a modular hazardous drug compounding platform, at its Pittsburgh headquarters in December 2025. The system aims to improve safety, workflow efficiency, and regulatory compliance in pharmacy operations dealing with hazardous drugs.PR NewswireRedefining Safety Standards: EQUASHIELD® Launches Game-Changing Safety Platform at ASHP 2025 in Las VegasEQUASHIELD is launching its integrated Safety Platform at the ASHP Midyear Clinical Meeting in Las Vegas, combining its CSTD technology with the Mundus HD automated compounding system and IV Workflow software. This solution aims to enhance safety and efficiency in hazardous drug handling by providing automated accuracy checks and seamless EMR connectivity.YahooEQUASHIELD® Launches CellSHIELD®: A New Era in Cell and Gene Therapy ManufacturingEQUASHIELD launched CellSHIELD, a closed, sterile, disposable device for cell and gene therapy manufacturing. It aims to reduce costs, improve efficiency, and support product safety, with a CDMO reporting less than 0.1% volume loss. The company will showcase it at the Cell and Gene Meeting in Phoenix.PR NewswireEQUASHIELD® Launches CellSHIELD®: A New Era in Cell and Gene Therapy ManufacturingEQUASHIELD launched CellSHIELD, a closed, sterile, disposable device for cell and gene therapy manufacturing. It aims to reduce costs, improve efficiency, and support product safety, with a CDMO reporting less than 0.1% volume loss. The company will showcase it at the Cell and Gene Meeting on the Mesa in October.PR NewswireEQUASHIELD® Marks 15 Years of Innovation in Healthcare Safety, Remaining the Top Choice CSTD for Hazardous Drug Preparation for Six Consecutive YearsEQUASHIELD Compounding Technologies celebrated its 15th anniversary, reaffirming its position as the most used Closed System Transfer Device (CSTD) for hazardous drug preparation for the sixth consecutive year. The company highlighted the launch of its new Mundus Mini HD automated compounding solution and noted a 32% increase in adoption since its initial recognition in 2019. These developments underscore EQUASHIELD's focus on enhancing safety and efficiency for healthcare workers handling hazardous drugs.